Longenesis

Longenesis a biomedical startup from Latvia focused on accelerating the R&D pipeline through health data. Longenesis has received innovation vouchers. The company has participated in various international startup acceleration programs, such as Europe’s “Headstart”, “MedTech Innovator”, “500 Startups” Global launch program in Singapore, “Salto” Accelerator, Estonia. Originally based in Hong Kong, Longenesis has developed a blockchain-based solution to apply data for research, while protecting privacy at the same time. Since that idea has emerged to providing digital tools for acceleration of biomedical research pipeline - the company has various platforms, such as Curator, Themis, and Engage (incl. Skrinings.lv) that help to identify potential partners in the ecosystem, help to enroll patients in research activities and promote proactive engagement. It is also listed as one of the Top 10 promising Latvia-based startups of 2021 by EU-Startups. In just 3 years of operation, Logenesis has attracted 30+ biomedical organizations and unlocking the potential for accelerating the R&D process around the globe, including National level projects in UAE, U.S., EU, and APAC regions.

Origin country: China
In Latvia since: Since 2020
Website:   //www.longenesis.com/ 

 

Sign up for newsletters

Stay up to date on the weekly newsletters on recent news and activities.

Subscribe

Sign up for newsletters

Stay up to date on the weekly newsletters on recent news and activities.

Subscribe

Please fill the input fields
Thank you the file has been successfully downloaded
Back